EMA Authorised: Intrarosa (prasterone) — Endoceutics S.A.

View source ↗

Summary

EMA authorises Intrarosa (prasterone) for postmenopause treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopause Conditions

Drugs mentioned

• Intrarosa (prasterone)

Snippet

Status: Authorised. Therapeutic area: Postmenopause. MAH: Endoceutics S.A.. Decision date: 07/12/2023